SCHEMBL4385022

SCHEMBL4385022

c1ccc(Cn2cc(-c3csc(Nc4ccccc4)n3)cn2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.55
SMN1; SMN2 Q16637 6/20 0.54
L3MBTL1 Q9Y468 2/20 0.52
AMY1A P0DUB6 2/20 0.52
NPY5R Q15761 1/20 0.52
VCP P55072 1/20 0.52
MAPT P10636 6/20 0.50
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
RAB9A P51151 4/20 0.50
NPC1 O15118 3/20 0.50
NFKB1 P19838 3/20 0.49
NFKB2 Q00653 3/20 0.49
RELA Q04206 3/20 0.49
GAA P10253 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MCL1 Q07820 1/20 0.49
CSNK2A1 P68400 2/20 0.47
DYRK3 O43781 1/20 0.47
ROCK2 O75116 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4243648 0.78 NPC1 (0.43) SMN1; SMN2L3MBTL1MAPTMEN1KMT2A
SCHEMBL7554523 0.75 ALOX5 (0.84) ALOX5SMN1; SMN2AMY1ANPY5RVCP
SCHEMBL1822611 0.75 SMN1; SMN2 (0.84) ALOX5SMN1; SMN2AMY1ANPY5RVCP
SCHEMBL2533440 0.75 RAB9A (0.51) ALOX5SMN1; SMN2VCPMAPTMEN1
SCHEMBL2532075 0.75 NPC1 (0.67) ALOX5SMN1; SMN2L3MBTL1MAPTMEN1
Bromide SCHEMBL7670429 0.74 ALOX5 (0.82) ALOX5SMN1; SMN2AMY1ANPY5RVCP
SCHEMBL29152948 0.72 ALOX5 (1.00) ALOX5SMN1; SMN2AMY1ANPY5RVCP
SCHEMBL369597 0.71 APP (0.56) SMN1; SMN2L3MBTL1MAPTMEN1KMT2A
SCHEMBL1886135 0.71 SMN1; SMN2 (1.00) ALOX5SMN1; SMN2AMY1ANPY5RVCP
SCHEMBL4064704 0.71 NPC1 (0.62) SMN1; SMN2L3MBTL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009010871-A2 PYRAZOLE DERIVATIVES AS ANTAGONISTS OF ADENOSINE A3 RECEPTOR ADDEX PHARMA S.A. (CH) 2009-01-22 WO disclosed